Verquvo

Active Ingredient(s): Vericiguat
FDA Approved: * January 19, 2021
Pharm Company: * MERCK SHARP DOHME
Category: Heart (Cardiac)

Vericiguat, sold under the brand name Verquvo, is a medication used to reduce the risk of cardiovascular death and heart failure.[2][3][4] It is taken by mouth.[2][3][4] Common side effects include low blood pressure and low red cell count (anemia).[3][4] Vericiguat is a soluble guanylate cyclase (sGC) stimulator.[2] It was approved for medical use in... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Verquvo 2.5 mg Oral Tablet, Film Coated

NDC: 0006-5028

Labeler:

Merck Sharp & Dohme Corp.

Verquvo 5 mg Oral Tablet, Film Coated

NDC: 0006-5029

Labeler:

Merck Sharp & Dohme Corp.

Verquvo 10 mg Oral Tablet, Film Coated

NDC: 0006-5030

Labeler:

Merck Sharp & Dohme Corp.